AR073848A1 - Utilizacion de la 4-(3-(hexahidrociclopenta(c)pirrol-2(1h)-il)propoxi)benzamida para la obtencion de medicamentos destinados al tratamiento de los trastornos del sueno. composicion farmaceutica. - Google Patents
Utilizacion de la 4-(3-(hexahidrociclopenta(c)pirrol-2(1h)-il)propoxi)benzamida para la obtencion de medicamentos destinados al tratamiento de los trastornos del sueno. composicion farmaceutica.Info
- Publication number
- AR073848A1 AR073848A1 ARP090103933A ARP090103933A AR073848A1 AR 073848 A1 AR073848 A1 AR 073848A1 AR P090103933 A ARP090103933 A AR P090103933A AR P090103933 A ARP090103933 A AR P090103933A AR 073848 A1 AR073848 A1 AR 073848A1
- Authority
- AR
- Argentina
- Prior art keywords
- benzamide
- treatment
- propoxy
- disorders
- hexahydrociclopenta
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0805721A FR2937251B1 (fr) | 2008-10-16 | 2008-10-16 | Utilisation du 4-{3-°hexahydrocyclopenta°c!pyrrol-2(1h)-yl! propoxy}benzamide pour l'obtention de medicaments destines au traitement des troubles du sommeil |
Publications (1)
Publication Number | Publication Date |
---|---|
AR073848A1 true AR073848A1 (es) | 2010-12-09 |
Family
ID=40416951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090103933A AR073848A1 (es) | 2008-10-16 | 2009-10-14 | Utilizacion de la 4-(3-(hexahidrociclopenta(c)pirrol-2(1h)-il)propoxi)benzamida para la obtencion de medicamentos destinados al tratamiento de los trastornos del sueno. composicion farmaceutica. |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR073848A1 (fr) |
FR (1) | FR2937251B1 (fr) |
WO (1) | WO2010043787A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2974729B1 (fr) * | 2011-05-02 | 2013-04-19 | Servier Lab | Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide et un inhibiteur de l'acetylcholinesterase et les compositions pharmaceutiques qui la contiennent |
FR2976285B1 (fr) * | 2011-06-08 | 2013-05-24 | Servier Lab | Procede de synthese et forme cristalline du chlorhydrate de 4-{3-[cis-hexahydrocypenta[c]pyrrol-2(1h)-yl]propoxy}benzamide ainsi que les compositions pharmaceutiques qui la contiennent |
FR2976286B1 (fr) * | 2011-06-08 | 2013-05-24 | Servier Lab | 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, son procede de preparation et les compositions pharmaceutiques qui le contiennent |
FR2983732B1 (fr) * | 2011-12-09 | 2013-11-22 | Servier Lab | Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}pharmaceutiques qui la contiennent |
FR2999179A1 (fr) * | 2012-12-07 | 2014-06-13 | Servier Lab | Procede de synthese d'un sel d'addition a un acide pharmaceutiquement acceptable du 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, ainsi que les formes cristallines associees |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2008
- 2008-10-16 FR FR0805721A patent/FR2937251B1/fr not_active Expired - Fee Related
-
2009
- 2009-10-14 AR ARP090103933A patent/AR073848A1/es unknown
- 2009-10-15 WO PCT/FR2009/001208 patent/WO2010043787A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2010043787A1 (fr) | 2010-04-22 |
FR2937251B1 (fr) | 2011-03-18 |
FR2937251A1 (fr) | 2010-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2024009274A (ja) | R-ケタミンおよびその塩の医薬品としての応用 | |
AR085219A1 (es) | 6-cicloalquil-pirazolopirimidinonas para el tratamiento de trastornos del snc | |
EA201290519A1 (ru) | Положительные аллостерические модуляторы рецептора хинолин амида m1 | |
AR073848A1 (es) | Utilizacion de la 4-(3-(hexahidrociclopenta(c)pirrol-2(1h)-il)propoxi)benzamida para la obtencion de medicamentos destinados al tratamiento de los trastornos del sueno. composicion farmaceutica. | |
EP2582676A4 (fr) | Modulateurs allostériques positifs du récepteur m1 de l'amide tétrahydroquinoline | |
CO6531470A2 (es) | Derivados benzamida sustituidos | |
RU2015143610A (ru) | Лечение катаплексии | |
UY26863A1 (es) | Derivados de la piperazina | |
BR112013004443A2 (pt) | composições farmacêuticas de (r)-1-(2,2-difluorbenzo[d][1,3]dioxol-5-il)-n-(1-(2,3-di-hidróxipropil)-6-flúor-2-(1-hidróxi-2-metilpropan-2-il)-indol-5-il)ciclopropano carboxamida e administração das mesmas | |
BR112015018168A2 (pt) | inibidores de rock suaves | |
JP2012504560A5 (fr) | ||
BR112015025804A2 (pt) | derivados de glutarimida, uso dos mesmos, composição farmacêutica com base neles e métodos para a produção de derivados de glutarimida | |
JP2019518732A5 (fr) | ||
JP2020503246A5 (fr) | ||
EA200801488A1 (ru) | Замещенные фенетиламины, обладающие серотонинергической и/или норэпинефринергической активностью | |
UY32526A (es) | Aplicaciones terapéuticas de derivados de quinazolinodiona | |
JP2019513755A5 (fr) | ||
UY27204A1 (es) | Derivados de pieracina | |
CO7200248A2 (es) | Derivados de etinilo como moduladores de la actividad de los receptores mglur5 | |
CL2012002259A1 (es) | Forma cristalina de 4-{(1s,2s)-2-[84-ciclobutilpiperazin-1-il-carbonil]ciclopropil}benzamida; composicion farmacéutica; y su uso para tratar enfermedades tales como esquizofrenia, narcolepsia, somnolencia diurna excesiva, obesidad, trastornos por deficit de atencion con hiperactividad, dolor, entre otras. | |
DOP2009000209A (es) | Sales de adición de ácido, hidratos y polimorfos de la etil-amida del ácido 5-(2,4-dihidroxi-5-isopropilfenil)-4-(4-morfolin-4-il-metil-fenil)-isoxazol-3-carboxílico, y formulaciones que comprenden estas formas | |
IL206615A (en) | The History of Pipridine Sulfonamide, the Process for Preparing it, Medicines Containing It, and Their Use in the Preparation of Medication for Treatment | |
IN2014KN01113A (fr) | ||
AR089112A1 (es) | Asociacion entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1h)-il]propoxi}benzamida y un antagonista de los receptores nmda y las composiciones farmaceuticas que la contienen | |
PH12015500346A1 (en) | Ethynyl derivatives as modulators of mglur5 receptor activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |